Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Probl Endokrinol (Mosk) ; 68(2): 4-8, 2022 01 25.
Artigo em Russo | MEDLINE | ID: mdl-35488751

RESUMO

BACKGROUND: The cocaine-amphetamine regulated transcript has been discovered long time ago (circa over 25 years ago) but still stays not enough investigated. Just during last five years scientist's society started providing interest to the genomic, proteomic and metabolic essence of the cocaine-amphetamine regulated transcript. AIM: The evaluation of historical pathway and perspectives of the cocaine-amphetamine regulated transcript medical investigations. MATERIALS AND METHODS: The literature search has been provided via Russian (eLibrary, CyberLeninka.ru) and international (PubMed, Cochrane Library) databases and among articles on Russian and English languages. The main criteria for article selection was free access and 2019-2021 years of publishing. Although the introduction is based on the articles published in 1989. The present article was created according to the federal project «Central and peripheral pathophysiological mechanisms of adipose tissue diseases and their clinical and hormonal manifestations патофизиологические механизмы развития болезней жировой ткани с учетом клинических и гормональных характеристик¼ (2020-2022)RESULTS AND CONCLUISON: It is necessary to keep on investigating genomic, proteomic and metabolomic markers because they contain important clues for successful resistance against human diseases. The 21st century is the era of transformation from simple clinical medicine to personalized science. For example, researches in the area of cocaine-amphetamine regulated transcript may result in invention of genetic medicine against dangerous metabolic diseases.


Assuntos
Anfetamina , Cocaína , Cocaína/farmacologia , Humanos , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/metabolismo , Proteômica , Federação Russa
2.
Biofizika ; 56(6): 1125-33, 2011.
Artigo em Russo | MEDLINE | ID: mdl-22279758

RESUMO

It is shown that metformin, which is a drug used for treatment of type 2 diabetes mellitus, metabolizes itself in vivo in the intestine and liver of mice with the release of nitric oxide. Subsequently the released nitric oxide forms paramagnetic mono- and dinitrosyl iron complexes which can be registered by EPR method. It is suggested that nitric oxide is just responsible for multifarious therapeutic action of metformin such as lowering of blood glucose level, reduction of arterial hypertension and other biological effects.


Assuntos
Hipoglicemiantes/farmacocinética , Ferro/sangue , Metformina/farmacocinética , Doadores de Óxido Nítrico/farmacocinética , Óxido Nítrico/sangue , Óxidos de Nitrogênio/sangue , Animais , Glicemia/metabolismo , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/tratamento farmacológico , Espectroscopia de Ressonância de Spin Eletrônica , Humanos , Hipertensão/sangue , Hipertensão/tratamento farmacológico , Hipoglicemiantes/farmacologia , Metformina/farmacologia , Camundongos , Doadores de Óxido Nítrico/farmacologia
3.
Klin Med (Mosk) ; 87(1): 40-5, 2009.
Artigo em Russo | MEDLINE | ID: mdl-19256259

RESUMO

The study was designed to evaluate external respiratory function (ERF) and cardiovascular function based on AP measurements, results of 24 hour AP monitoring, treadmill test, and ECG during weight loss therapy in patients with excess body mass. A total of 93 patients with grade 2-3 obesity were examined including 41 (39.8%) with type 2 diabetes mellitus (DM). Group 1 consisted of patients with constitutive exogenous obesity, group 2 of patients with constitutive exogenous obesity and DM, group 3 was used as control. Follow-up studies were conducted after 6 and 12 months. Patients of groups 1 and 2 showed positive dynamics of hemodynamic characteristics related to the loss of weight including significant reduction of heart rate, systolic and diastolic indices of hypertonic loading, specific peripheral vascular resistance, and left ventricular mass. Simultaneously, cardiac index and ERF increased while vital lung capacity, forced vital capacity, and forced respiratory volume in the first second returned to normal values. It is concluded that reduction of body weight has positive effect on ERF dynamics and hemodynamic characteristics in patients with constitutive exogenous obesity.


Assuntos
Terapia por Exercício/métodos , Tolerância ao Exercício/fisiologia , Obesidade Mórbida/fisiopatologia , Mecânica Respiratória/fisiologia , Redução de Peso/fisiologia , Adulto , Pressão Sanguínea/fisiologia , Monitorização Ambulatorial da Pressão Arterial , Índice de Massa Corporal , Testes Respiratórios , Eletrocardiografia Ambulatorial , Teste de Esforço , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Obesidade Mórbida/terapia , Prognóstico , Resistência Vascular/fisiologia , Adulto Jovem
5.
Probl Endokrinol (Mosk) ; 36(3): 29-33, 1990.
Artigo em Russo | MEDLINE | ID: mdl-2395828

RESUMO

The authors presented the results of catamnestic investigation of 133 women treated with bromocriptine for various types of hyperprolactinemic hypogonadism. A high effectiveness and safety of bromocriptine therapy were observed. Methods of prevention of probable complications were proposed. The authors evaluated the health status of children born to patients treated with bromocriptine. The most prolonged remissions were observed in patients with macroprolactinemia who gave birth to children owing to bromocriptine therapy. Most patients develop a relapse of the disease after therapy discontinuation and therefore need repeated therapeutic courses. In the authors' opinion, prolonged bromocriptine therapy is a serious alternative to surgery and radiotherapy.


Assuntos
Bromocriptina/uso terapêutico , Hiperprolactinemia/tratamento farmacológico , Adenoma/sangue , Adenoma/complicações , Bromocriptina/efeitos adversos , Avaliação de Medicamentos , Síndrome da Sela Vazia/sangue , Síndrome da Sela Vazia/complicações , Feminino , Humanos , Hiperprolactinemia/sangue , Hiperprolactinemia/etiologia , Hipogonadismo/sangue , Hipogonadismo/tratamento farmacológico , Hipogonadismo/etiologia , Neoplasias Hipofisárias/sangue , Neoplasias Hipofisárias/complicações , Gravidez , Prolactina/sangue , Indução de Remissão
6.
Probl Endokrinol (Mosk) ; 35(4): 33-7, 1989.
Artigo em Russo | MEDLINE | ID: mdl-2602349

RESUMO

The paper is concerned with the use of a new tomographic method based on the principle of nuclear magnetic resonance (NMR-tomography) in the diagnosis of adenohypophyseal diseases. A NMR-tomograph with a resistive magnet (0.234 T) was employed. Altogether 15 patients with the most common types of hypothalamo-hypophyseal diseases including Itsenko-Cushing disease (6) of various degrees of severity, hyperprolactinemic hypogonadism (8), and one patient with acromegaly were investigated. NMR-tomography was shown to possess a high informative value permitting assessment of the presence of adenohypophyseal pathology without irradiation of a patient. NMR-tomography combined with routine methods of examination of patients with hypothalamohypophyseal pathology (roentgenography, computerized tomography, hormonal investigation) made it possible to improve considerably early diagnosis of pituitary adenomas and to specify the volume and type of tumor growth.


Assuntos
Adenoma/diagnóstico , Imageamento por Ressonância Magnética , Neoplasias Hipofisárias/diagnóstico , Acromegalia/diagnóstico , Acromegalia/patologia , Adenoma/patologia , Adulto , Síndrome de Cushing/diagnóstico , Síndrome de Cushing/patologia , Diagnóstico Diferencial , Feminino , Humanos , Hiperprolactinemia/diagnóstico , Hiperprolactinemia/patologia , Hipogonadismo/diagnóstico , Hipogonadismo/patologia , Masculino , Pessoa de Meia-Idade , Adeno-Hipófise/patologia , Neoplasias Hipofisárias/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA